Virbac SACA

Virbac : Declaration of the number of shares and voting rights June 2022

07 Jul 2022 11:42:42 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 05/2022

03 Jun 2022 10:22:29 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 04/2022

06 May 2022 03:41:36 By Nasdaq GlobeNewswire

Release of the annual financial report as of December 31, 2021

28 Apr 2022 09:26:08 By Nasdaq GlobeNewswire

Virbac : Very strong growth in revenue in the first quarter of 2022 of +16.2% at comparable exchange rates (+19.3% at real rates), driven by good performance in all areas

14 Apr 2022 11:02:29 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 03/2022

04 Apr 2022 03:48:54 By Nasdaq GlobeNewswire

VIRBAC: 2021 operating profit from ordinary activities showed very strong growth, reflecting the excellent dynamism of our business in a rapidly growing market

22 Mar 2022 11:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 02/2022

01 Mar 2022 10:24:52 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 01/2022

28 Feb 2022 11:26:06 By Nasdaq GlobeNewswire

VIRBAC: Exceptional growth in annual revenue of +18.4% at comparable exchange rates and scope (+14.9% at constant rates and real scope), driven by remarkable performance in a very buoyant market

19 Jan 2022 10:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 12/2021

07 Jan 2022 05:02:25 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights November 2021

06 Dec 2021 04:53:38 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights October 2021

05 Nov 2021 04:42:52 By Nasdaq GlobeNewswire

Virbac: Aquaculture - Virbac completes the acquisition of Centrovet

05 Nov 2021 02:14:06 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 09/2021

19 Oct 2021 06:45:30 By Nasdaq GlobeNewswire

Virbac: excellent revenue growth of 21.2% at the end of September at comparable exchange rates and scope (+16.4% at constant rates and real scope), driven by a very solid third-quarter performance again in all areas

18 Oct 2021 10:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 08/2021

16 Sep 2021 11:47:17 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 07/2021

16 Sep 2021 11:42:52 By Nasdaq GlobeNewswire

Virbac : availability of half year report

15 Sep 2021 11:31:54 By Nasdaq GlobeNewswire

Virbac: Significant increase in operating profit from ordinary activities for the first half of 2021 due to the sound market performance and dynamism of our business

15 Sep 2021 10:45:00 By Nasdaq GlobeNewswire